To further verify whether chaetocin exhibits anticancer effects via Hippo pathway in ESCC cells, TE-1 and KYSE150 cells were treated with the Mst1/2 inhibitor XMU-MP-1 (1 μM) for 24 h before chaetocin treatment. Here, MST1 is linked to esophageal squamous cell carcinoma.